Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

RNase 8 Activators

RNase 8 activators encompass a variety of chemical compounds that function through distinct biochemical mechanisms to enhance the activity of this enzyme. Certain activators operate by elevating intracellular levels of cyclic adenosine monophosphate (cAMP), a pivotal second messenger in multiple signaling pathways that can influence phosphorylation states and the functional regulation of various proteins. This increase in cAMP can be achieved by directly stimulating adenylate cyclase, thereby enhancing the production of cAMP, or by inhibiting phosphodiesterases, which are responsible for cAMP degradation. As cAMP levels rise, protein kinases are activated, which may then phosphorylate proteins involved in the regulation of RNase 8, leading to its enhanced activity. Furthermore, some activators modulate calcium signaling pathways by increasing intracellular calcium concentrations. This can be achieved via calcium ionophores or by the activation of L-type calcium channels, subsequently triggering calcium-dependent protein kinases that could play a role in upregulating RNase 8 activity.

Additionally, certain compounds activate protein kinase C (PKC) which is involved in various cellular processes, including the regulation of protein function through phosphorylation. Activation of PKC could modulate the activity of proteins that are part of the regulatory network of RNase 8. The modulation of intracellular calcium levels by activators also exerts an effect on calcium-sensitive signaling cascades, potentially leading to alterations in protein interactions and activities that can influence RNase 8.

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cilostamide (OPC 3689)

68550-75-4sc-201180
sc-201180A
5 mg
25 mg
$90.00
$350.00
16
(1)

Inhibits phosphodiesterase type 3, increasing cAMP levels and potentially promoting the activation of RNase 8 through cAMP-dependent pathways.